These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 19708024)

  • 1. Identification and targeting of cancer stem cells.
    Schatton T; Frank NY; Frank MH
    Bioessays; 2009 Oct; 31(10):1038-49. PubMed ID: 19708024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The therapeutic promise of the cancer stem cell concept.
    Frank NY; Schatton T; Frank MH
    J Clin Invest; 2010 Jan; 120(1):41-50. PubMed ID: 20051635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor cells positive and negative for the common cancer stem cell markers are capable of initiating tumor growth and generating both progenies.
    Huang SD; Yuan Y; Tang H; Liu XH; Fu CG; Cheng HZ; Bi JW; Yu YW; Gong DJ; Zhang W; Chen J; Xu ZY
    PLoS One; 2013; 8(1):e54579. PubMed ID: 23349932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting stem cells-clinical implications for cancer therapy.
    Tu LC; Foltz G; Lin E; Hood L; Tian Q
    Curr Stem Cell Res Ther; 2009 May; 4(2):147-53. PubMed ID: 19442199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer.
    Ring A; Kaur P; Lang JE
    BMC Cancer; 2020 Nov; 20(1):1076. PubMed ID: 33167919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
    Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
    Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour stem cell-targeted treatment: elimination or differentiation.
    Massard C; Deutsch E; Soria JC
    Ann Oncol; 2006 Nov; 17(11):1620-4. PubMed ID: 16600978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer stem cells and human malignant melanoma.
    Schatton T; Frank MH
    Pigment Cell Melanoma Res; 2008 Feb; 21(1):39-55. PubMed ID: 18353142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.
    Eun K; Ham SW; Kim H
    BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
    Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
    Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNAs in cancer stem cells: Biology, pathways, and therapeutic opportunities.
    Asadzadeh Z; Mansoori B; Mohammadi A; Aghajani M; Haji-Asgarzadeh K; Safarzadeh E; Mokhtarzadeh A; Duijf PHG; Baradaran B
    J Cell Physiol; 2019 Jul; 234(7):10002-10017. PubMed ID: 30537109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular iodine inhibits the expression of stemness markers on cancer stem-like cells of established cell lines derived from cervical cancer.
    Bigoni-Ordóñez GD; Ortiz-Sánchez E; Rosendo-Chalma P; Valencia-González HA; Aceves C; García-Carrancá A
    BMC Cancer; 2018 Sep; 18(1):928. PubMed ID: 30257666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of liver cancer stem cells and clinical correlations.
    Cheng Z; Li X; Ding J
    Cancer Lett; 2016 Sep; 379(2):230-8. PubMed ID: 26272183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hitchhikers guide to cancer stem cell theory: markers, pathways and therapy.
    Fábián Á; Vereb G; Szöllősi J
    Cytometry A; 2013 Jan; 83(1):62-71. PubMed ID: 22997049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual Effects of Non-Coding RNAs (ncRNAs) in Cancer Stem Cell Biology.
    Kyriazi AA; Papiris E; Kitsos Kalyvianakis K; Sakellaris G; Baritaki S
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32932969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research progression of CD133 as a marker of cancer stem cells.
    Zhang H; Li SY
    Chin J Cancer; 2010 Mar; 29(3):243-7. PubMed ID: 20193104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Die hard: are cancer stem cells the Bruce Willises of tumor biology?
    Fábián A; Barok M; Vereb G; Szöllosi J
    Cytometry A; 2009 Jan; 75(1):67-74. PubMed ID: 19051297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of cancer stem cells.
    Yang C; Jin K; Tong Y; Cho WC
    Med Oncol; 2015 Jun; 32(6):619. PubMed ID: 25920610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colon cancer: cancer stem cells markers, drug resistance and treatment.
    Kozovska Z; Gabrisova V; Kucerova L
    Biomed Pharmacother; 2014 Oct; 68(8):911-6. PubMed ID: 25458789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.